Braun Stacey Associates’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-20,325
Closed -$1.59M 117
2024
Q2
$1.59M Sell
20,325
-47,503
-70% -$3.71M 0.06% 93
2024
Q1
$4.6M Sell
67,828
-43,676
-39% -$2.96M 0.18% 89
2023
Q4
$7.51M Sell
111,504
-28,590
-20% -$1.93M 0.34% 88
2023
Q3
$9.49M Sell
140,094
-35,305
-20% -$2.39M 0.46% 84
2023
Q2
$12.6M Sell
175,399
-150,879
-46% -$10.8M 0.58% 82
2023
Q1
$22.6M Buy
326,278
+184,006
+129% +$12.8M 0.59% 84
2022
Q4
$9.65M Sell
142,272
-24,786
-15% -$1.68M 0.55% 83
2022
Q3
$9.16M Sell
167,058
-37,955
-19% -$2.08M 0.56% 84
2022
Q2
$13.5M Buy
+205,013
New +$13.5M 0.77% 61
2017
Q1
Sell
-9,100
Closed -$249K 142
2016
Q4
$249K Sell
9,100
-4,000
-31% -$109K 0.02% 150
2016
Q3
$430K Hold
13,100
0.03% 129
2016
Q2
$395K Hold
13,100
0.03% 132
2016
Q1
$369K Hold
13,100
0.02% 136
2015
Q4
$445K Hold
13,100
0.03% 122
2015
Q3
$417K Sell
13,100
-22,900
-64% -$729K 0.03% 122
2015
Q2
$573K Buy
36,000
+20,800
+137% +$331K 0.02% 226
2015
Q1
$520K Buy
15,200
+5,800
+62% +$198K 0.03% 115
2014
Q4
$331K Hold
9,400
0.02% 135
2014
Q3
$336K Sell
9,400
-600
-6% -$21.4K 0.02% 133
2014
Q2
$372K Sell
10,000
-2,000
-17% -$74.4K 0.02% 125
2014
Q1
$389K Hold
12,000
0.02% 121
2013
Q4
$356K Hold
12,000
0.02% 121
2013
Q3
$312K Hold
12,000
0.02% 123
2013
Q2
$284K Buy
+12,000
New +$284K 0.02% 134